0000950103-14-008296.txt : 20141125 0000950103-14-008296.hdr.sgml : 20141125 20141125114902 ACCESSION NUMBER: 0000950103-14-008296 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20141124 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20141125 DATE AS OF CHANGE: 20141125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Shire plc CENTRAL INDEX KEY: 0000936402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29630 FILM NUMBER: 141248470 BUSINESS ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 ZIP: R924 8EP BUSINESS PHONE: 441256894000 MAIL ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 ZIP: R924 8EP FORMER COMPANY: FORMER CONFORMED NAME: Shire Ltd. DATE OF NAME CHANGE: 20080523 FORMER COMPANY: FORMER CONFORMED NAME: Shire plc DATE OF NAME CHANGE: 20051125 FORMER COMPANY: FORMER CONFORMED NAME: SHIRE PHARMACEUTICALS GROUP PLC DATE OF NAME CHANGE: 19980302 8-K 1 dp51389_8k.htm FORM 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): November 24, 2014

Shire plc
(Exact name of registrant as specified in its charter)

Jersey, Channel Islands
 (State or other jurisdiction of incorporation)

0-29630
98-0601486
(Commission File Number)
(IRS Employer Identification No.)

5 Riverwalk, Citywest Business Campus, Dublin
24, Republic of Ireland
(Address of principal executive offices)
(Zip code)
   
Registrant's telephone number, including area code
+353 1 429 7700

 
 (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.f13e-4(c))

 
 
 
 
Item 8.01. Other Events

Shire plc have issued the press release attached hereto as Exhibit 99.1 which is incorporated by reference herein.
 
 
Item 9.01. Financial Statements and Exhibits

(d)  Exhibits.  The following exhibit is filed herewith:

99.1
Press Release dated November 24, 2014

 
 
 

SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
SHIRE PLC
  
         
         
 
By:
/s/ T May
  
   
Name:
Tatjana May
  
   
Title:
General Counsel
  
 
Dated: November 24, 2014

 
 
 

EXHIBIT INDEX
 
Number
Description
   
99.1
Press Release dated November 24, 2014



 
 
 
 

 
 EX-99.1 2 dp51389_ex9901.htm EXHIBIT 99.1
 
Press Release
www.shire.com
 
 
BLOCK LISTING SIX MONTHLY RETURN

 
November 24, 2014 - Shire plc (LSE: SHP, NASDAQ: SHPG)
 
 
Name of applicant:
Shire plc
Name of scheme:
2000 Executive Share Option Scheme
Period of return:
From:
May 23, 2014
To:
November 22, 2014
Balance of unallotted securities under scheme(s) from previous return:
3,406,623
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
Nil
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
Nil
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:
3,406,623

 
Name of applicant:
Shire plc
Name of scheme:
Shire Sharesave Scheme
Period of return:
From:
May 23, 2014
To:
November 22, 2014
Balance of unallotted securities under scheme(s) from previous return:
210,392
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
Nil
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
2,634
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:
207,758
 
 
 
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
 
 
 
 
Name of applicant:
Shire plc
Name of scheme:
Portfolio Share Plan
Period of return:
From:
May 23, 2014
To:
November 22, 2014
Balance of unallotted securities under scheme(s) from previous return:
1,594,259
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
Nil
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
456,045
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:
1,138,214


Name of applicant:
Shire plc
Name of scheme:
Employee Stock Purchase Plan
Period of return:
From:
May 23, 2014
To:
November 22, 2014
Balance of unallotted securities under scheme(s) from previous return:
422,301
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
500,000
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
397,591
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:
524,710


Name of contact:
Tony Guthrie, Deputy Company Secretary
Address of contact:
Hampshire International Business Park
Basingstoke, Hampshire, RG24 8EP
Telephone number of contact:
01256 894746
 
For further information please contact:

 
Investor Relations
    
     
Jeff Poulton
jpoulton@shire.com
+1 781 482 0945
     
Sarah Elton-Farr
seltonfarr@shire.com
+44 1256 894157
 
 
 
 
 
 
NOTES TO EDITORS
 
Shire enables people with life-altering conditions to lead better lives.
 
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
 
We focus on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.
 
www.shire.com
 
 
 
 
 

 

 GRAPHIC 3 logo.jpg GRAPHIC begin 644 logo.jpg M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC M+B!6,2XP,0#_VP!#``("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(" M`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@+_Q`&B```!!0$!`0$! M`0```````````0(#!`4&!P@)"@L!``,!`0$!`0$!`0$````````!`@,$!08' M"`D*"Q```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$( M(T*QP152T?`D,V)R@@D*%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W M^/GZ$0`"`0($!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&A ML<$)(S-2\!5B7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H MJ:JRL[2UMK>XN;K"P\3%QL?(RKR\_3U]O?X M^?K_P``1"``Z`+,#`1$``A$``Q$`_]H`#`,!``(1`Q$`/P#]_*`"@`Z>WZ4; M;:?A8-OE\MQ.GMC^M&VR^6P?A^%CR'XG?&[P+\*(47Q#J#3ZM/&9+/0=.5;C M4YT[2O'N5+6`GCSKAHU;^#?@U]!DG#.:9Y-K!T>6C%VE7J>Y2B^J3^T^Z6W5 MGR_$'%V3\.0_VNM>O:\,/2:E4VNG)+6"?1V=^UCX]UG]N+Q#+<,GAWP1IEI; MEBL)U6^N+JZ<$X3?%:)#$CG/W4DE!/`8U^BX;PNP\:498O,IJ=M8PIQA%/JD MVY???Y'Y5B_&#%RJ..`RV$8IVC)RYI-=W%Q_)&;_`,-L_$"V26&Z\'^'%NO+ MQ&QDU&'R7/1I8&=F(_V-T9]\=>C_`(A=@&TX9A7Y;[O9V.7_B+^:0C*,L M!14TK)MQBTWUY5!+Y6-[X>_';XJ?%/5CI$/Q+\%^`M4EEV6&D77A=+A[\8W! M;2\ODN8))3]TP-(DS`YC4G&.+.>%LGX>H0JSR2MFE))^UK0Q>+IRIV_GA2Q% M-*+5_>4;+J=^0\99_P`0XAX>.?4LIJ.7[JE/!Y?*,[M)1C.IA)OF=^OWGO\` M9>-OBQ\/];BT?XG0:)XFT?4M+UN[T;Q3X=@;37_M'1=,N-5;2M2L&`BA>]MK M6;[/<1K'&)`005!Q\96P.29EA_;Y3[3`XB%>A2J8&I*=2*A7JJG[2%2K4G)V MNF_>?:R;N?=T] M&ZO<\?3]NK0V17_X5]K0W(&Q_:FG\9&<9Q7U+\+<6DW_`&A#17TH]E=_\O3Y M)>,.$NE_9S7O67[V6FMOY3[-\$^)H_&?A/P_XJAM)+"+7]+M-3CLY7226U6[ MB$HA>2/Y'=`V"R_*>HK\US#!RR_&XC!RES/#3<')+E3?5VZ;GZSE./CF>7X; M'1A[-5XQGR\KI\W1/^:-O MB\SX+BSCBCPMB*.'J87VSJ14D^=P2NO),S_@]^TMIOQ<\57'A>S\+:CHDD&D M76K?:[N]M)XV2VN+2W,`C@^<.YNPP;[H"$'J*VXDX+K\.8.GBZN*5:-2O&BH M1I\EFXRE>_/+^7:R,.%./J/$V85,!2P;P[IX>5?GYV[\K2M:R[GT[T_#\.M? M$KRT_`_1/+;R["T`%`!0`4`%`!0`4`%`!0`GZ?TI;=/T"UOZV/-OBC\2="^& M7A74M;U2^M(;Y;2X_L7399E6YU341&1;V]O"#YD@,I3S65=D:9+,.,^SD>38 MC-\;1H4:]];6/G^(L^PN19?7KU*M..)]E+Z MK0;O.I5>D4H1N]]=;)VM>Y^4MSX-\1^)/MGQ+^*FN'PKI.KSR7:ZCJTXAX2CB)RG15=MU:R;NJ=*.\ M5K9727GH?2O@+]F2Z\3:#9ZQ977_``@&CZG;IL>-[^TF7=%=:A?2- M%8Z-'XE.,?%YEQU/+\75H./UW$4IC=]$TS[[)O#K^T,#2Q,)0P6&K0YJ2J1D\6XO:;G%-_ MV*_$.E:==ZIX2\41^(;BVCDN'TG4+0V=[=*@+LEI)E"I6IT,=@WAX5)*"JPE%TZ=]$Y*RDE=ZM+3=G%G/A+B\-AZN*P&,A7 M=.,IRHR4_:244V^5VM?3;=]#XD(N+*Y(_?6EY:3D<%H9[:YMY,$@KAXIH95( M^4@JX]:_5+4<50^S4HU8>L91DOR/Q[]_@,1HYT:U">EGRRA-/\&?J-\*O&9^ M*7P0U'5M>E>Z\1^"-&\5:7<3,R@W-Q_PC=U!;:E.FTDS36%T5+@KFX$SXSC' M\_<0Y4LCXEI4,/%T\+C,7A:M/IRI8B$ITXVLN52L]NJ1_2O"^;_ZP<)XBOBG MSXK`8#&TI]O>P]10E+KS)1W/RNB_U$7;]TGMCY!7]#:1@]-.1_\`I.Y_,BM& M:_QK3M[Q^W?P+_Y(_P##G_L4](]O^75*_E?B33/,RMTQ,K>5TC^QN#].',LT MM^XVVM[TCU;(]OSKQ+6Z6_`^DO'NOO0M%OE^`]OE^I\H_'_]GG6OC#K^AZQI M?B+2]$CTG2YM/DAOK6ZG>9Y;GSQ(C6Y"JH'RD'G//2ON^$N+Z/#5"O1J8.KB M'6J<[-BK:LI4?,2X(X! MK?BSC6CQ%@*6"I8*MAI4\3&OSSJ0DFHPE'E2CJG[U[F'!?A]B>%JC\T@!].W]:-O+\!IKHU\O^`+0 M`4`)1;MZ!MM_D'`]OTQ1KI]GR#]/U/G/XJ?'B#PMJ4?@;P%IS>,_B3J'[FVT MBQ!GM-(=^/M&KRPG]UY0/F-;ED*H-\[Q)R?KHX7]Y;M/1= M3S"\^$>N^%_#7B3XQ_$AHOB3\3=-TR75=.T2^9Y?#.A&+:YBM+%08[@V,3/, M%5$AS$5B7',9@;;H8:25U:*?+-QTTM:^]]4?GAXL\6^( M?'&K7&M^)M2GU&^N,JA<[;:SA.2EM86RD0V=K&#B.&%57`^8LQ)/[9EV4X/* M\)]6P=*-.#BTY+XIN2LZCF]92ENVVV^Y^!9CF^.S+&?6L75E*49IQI_#"FHN MZA&"M%)+39'Z-_"3]J_X?7'A_1-!\7RS>%M8TS3[337GF@DET>Z%G`EO'/#= M0AVA,J1JSPS1C8Q.'(P:_%>(.`ZY=+7T?5GU?HOBKPQX MC@6XT'7]'U>%E#*=.U"UNBNX9"ND,K/&^#RDBJXZ,`17P>(P&.P;:Q&$Q%#E M=KU*4X13\I./+]S/TG#9KEF,C'ZKCL+64EI&G6@Y:]'%/F7S1\S>(OV.OA_X MAU_6=?DUOQ%8RZSJ5UJ4MI9R6:6MO+=R&62*W1K9F6(.S%06)Y.2:^TP'B'F MN!PE#!PH491P].--2E.2DU%;M):?(^`S#PLR?'XW$XR6)K4I8BK*JX0IQY8N M71>\M#L/#7P:T'X.?#_XD6.@ZEJM_%K6@:M=3_VG)`Q@DM=$U")?($,40`D6 M3]YD$DHOO7F8_B'$\09IE57$TJ=&6'Q-&$?9MV:G7IMMMI6M8]C+>%<)PMDV M=TL)6J5(XC!8F4N>*CRN.&JK2S??R/QWBQY$7_7)..G\`_G7],62@E97Y=/* M\=#^3%[LHVVY[O\`\"U]#[`U;]I[6O#OP\\$^`_A])'876E^%]+M=<\02Q+) M/'>+:QB2QTN*7=&C6YRL]W*CDR92%!M,A_,<+P'1Q.:XW,V]CXI\5\0QJ^TEF->-35[M:[_#>R5SZI^`G[4?B?_A)-,\(? M$2_75]+U>XBL+'7)TCAO]-OISLMEO)8PD=S9SR%83(Z+-"[JY=U+`?"<6\!X M2G@ZN89/3]A/#P]S])X(\1\=+&T,MSFK[>E7D MJ=*NTE.$Y.T4[+X>]V=S^U9\6O'_`,//%/AG3_!^O/I-G?Z)<7=U$EM:SB2= M+SRUDS/%(RX3Y<*0#UQ7D\`!K2T@$=]:3V"P3AH88V)19I!M)*'=DC@5W\:\,9/E.!P5;!86-"=3,:-&; M3;;ISC)RC\['F:5*$V^:2U:N M[ZGQV*\0N*:6+Q%*&83C&%>I"*Y8Z14FNW8]S\9?M8:_HO@7P?H?AZXM[WQO M?^&[&^\3^(;B&*2+3;BZ5S]GM[6/;"^HLF))"Z^5;!E!C=R0ORV6>'U'$9MF M%;&0E0RZABIPPF'3-_$][!?>(;2&\M)=6NU ML9X96;S('L8Y$M3"W&8Q"$..G%?0\1<.9+@(<$L5CZLHU*JYHMVBXN2NK+1;GUS\>/VI+?P!>W/A'P/#::K MXHMALU'4+DF73-$E8#]QY<;K]LOP#EX=Z10'"REGR@^`X5X%JYM"&-S"4\-@ M[ITX)> MG8^#-;^-GQ8\07,D]]X]\1QE\G[/IFH3:7;*#_"MMIYMX]N.@8,?4DU^L4>% M.&\%",8X##Q<5[LZEG*_>\KM/SO<_%\1Q?Q-CZLI2QV(EN^2FG&U];6C;8U/ M#'[07Q=\*W4=Q9^,]5U.)&!DL=?G?5[68`Y:-Q=LTZ*1QF&:)E'(/%88O@KA MW&T7&&"I49--1JT7R.+>S7)97_!]3;+^.N)LKJQ?UVI*,6FZ-5:-=GS7>I^E M'P+^.^C_`!?TR:WD@31_%>EQ(VJ:/YFZ.2)L+_:&G.V'EM'DRKHP\RWX M;P]'"//L]?L;.6<@+X>?\0XC.*RA'_9\!1?+A<+#W81A'2,I1 M7NN36O97LN[^CX8X5PV04%5J6KYE57-B,5/WI\\M9*$GJE>_F_0]FF@BGAEM MYXTD@GC>&:)U#))%(I22-U/#*ZDJP/!!P:^?A*5.49PDX2IM2C*+Y7&2=XM- M;.^J9]54IPJ4YTIQ4JT.GO*1%>VNYCY,;/'/$HV?O`!G]HX;\0\/[&E@\X;H5 M::C".*2_=S2T3DHZQD_M-VCK>ZV/Y_XK\+\73KUL=D477H5)2F\*M*E.3NWR M[+E3VMTW/C;6/#^N>'KEK+7=&U/1[F,D-#J-E<6C#J,KYL:*ZYZ/&60]037Z M;A,RP.,A&IAL31J0>SC.*?W7/R7%95C\!-T\5A*U":WBX2LK;ZI612LKV\TV M5;C3;RZL)U.4FLKF6UD4@@Y#P,C9SSG-:UL)A<0N6O1HUH]%."DO\C+#XS&8 M*2>&KUL-+^Y*4'^!]`^`OVGOBEX)N(([S5W\6:/&5$VFZ\YGG\K(W"UU/'VR M&0+GR_-:>,'`*`$U\;G'`639A"N\;ADTIPKMSGR]>63?NZ=4?HMI/Q*\/?%+X2>*/$?A]W1?^$9\0 M6^H:?/M6\TN^71[EI;6Y53@_>W0S+^[GB*NG4JOXMB1YWA,'B86MC,.Z MWA:4?/^97O%O4_?<)G^#XAX5M#^0/*WVFNV[?0_3C]E[X&^$/^$%TSQQX MFT.QUO6_$/G75FNJ6\=U;Z9IR32P6R6]M,'@$MPL9N'G9&DVR(J,H!W?A''/ M%&82S6OE^#Q%7#8?"6@_8R=.52(Q&+O*,:T5*-*,6U[J?5_UJ;/[2_P`%O!EW\.=;\4:%X?TW1/$'AF!-1AGT MJTAL1>6D\3!5,-6I:\LZ4 MHOTDMG]Y_-V%FZ&*H5(^[*G6A)-:6<9?F?7O[7EXVH:I\,-08Y:^\!V]XQY& M3=4HJT:>85X1\E&227W(_3O$R;FLCJ2^*>782; M[WE13;_$Q_V1?^2B>)/^R=^(O;_EYTRNKQ'5LKRZW_0VPWE]F9S>%^F:YIY9 M+C/E>*/EZZXNKK_KZN/_`$<]?=X+_<\,MOW%/_TE;GY[F&F.Q?\`V$5?*WOL M^FOV>OV>O^%M->:_X@N[K3?"6FW7V,+9[4O=8OE57F@AFD5A;VUNC(LTZJ[M M(WE(!M9A\+QEQB\A<,'@H0GC*D.=N6L*4-5S2BM>:ZT6E]==-?T+@3@5<1JI MC,;.=+`T9(L[XBS'#Y5B:M&>'Q4_P!] M#V3BG2@G.<5[VG-%6^9^CY]PKP]POE&(S;#4:U/$86"A1FZBO&I4]V,G[JN^ MNC1^9MM!?:[K%O;M.9=2UK4XHGN;E^9+O4+A5>XN)&.?]9*TLC$C@'I7[G4= M++\#)THK;;['[% M?#KX7?"SX>Z#9:;9VWAN]U%;>/\`M/6+\Z?!=2\%W_`(T\ M,0Z%IOB+P]LO+L:4]G;C5M-+K%'S%GAE">=\A1F92`/IN!\]S? M#9G2P&,>+JX7%/V<76C5?L:FZDIR7NJ233N[7MMK?Y+Q#X,;SP%X^\,^);.9XDM=2MX-016*) M<:7>2+!?P2`8W*T+F15/'F1HW&*_5N),LI9ID^,H5(J\:,ZE)VUC4C%R@_E* MS/QGA7-*V39W@<12FXJ5:G3J).R=.4ESI^JNC]R894GABGC(,)DF@L&0_O-*T\#R[K5`N"/-!80V8(YG;S.1%S] MIP5PY_;.->(Q,/\`8,%[]6]TJDUJJ:>FD=)27HMFS\_\0>*7D.7K"8.=LPQB M]G347[U*$].>W1RNXKROY$?[,/PCC\"^$T\5:U"9O&7B^)-1OKFY^>YL;"ZQ M/;V(=LL))@PNKUN'>>0(_P#JQ1QIGW]HXYX'"OV>78!NE2IP]V$YQT3?%7XP>'/A#::1>^(K35+B'6+JXM+;^S((YC'+;Q)*WG!Y8]@= M7^0C))!SC%>[D7#^,S^M4H8*5.$J4%.7M)6^'OVN_AMXBUW2-`M+#Q%;76L:A;:=;RW-E#';1S74@CC:9UN M&*1[B,D*3STKW\9X>YU@<-5Q4W0<*$)3DH2?-9*[L?,X'Q/R''XJC@Z4,3"I M5DH0C/T#$8/"8F#A7PU*I%K:=./5=':Z]4T>"^, M?V6OA%XJCF>WT$>&-2D5BNH:!*]J%D(.UGL69[%U5CN*)!$6_B?I7U67<<9_ ME\HWQ;U/C,U\.>&\QIRY,)'!5VG:M1NW=ZZQD[;]F MC\Q/BG\.-3^%?C&^\)ZE<)>+%%%>:=?Q(8EOM/N2WD3F/)\J4%'BGC!*K*C! M25P:_=^',\I9]EL,;3BZG)42]Y)]5U3ZW/YRXHX?J\-9I4R^K)2BE MST9[<])OW9/M?MTZGKO[,&O7=EJ'Q+\/+(WV#6?AOXENI(`2$%WIMA.T4^T# M:'$,LT63@D-U/2OE^/\`!TIT\IQB2C4H9EA(1LE=JK7A%IO3U/K_``VQM:E4 MSG`IOV-?*.,1)[=4%?HCTAV:A]UHGY?%>^K: M>]MM]H_;KX%@+\'_`(=!0%'_``BFDG`XY-LA)X[DDD^YYYK^6.)6_P"W#DH\.96HZ)4';IO.5QWQR_P"21?$#_L6K_P#]`%7PMIG^5VZ8 ME6_\!D'&.G#6;>6&_.<3\1APH_W5]NPK^H9_P9?X/T/X^AI773]Y_P"W'UG^ MU1U^#W_9--,_]`MJ_.O#_P#C9]_V,\3_`.EGZ;XC_P`+A_\`[%6"_P#3**W[ M(O\`R47Q)_V3OQ'_`.E.EUOXC_\`(KR[_L;8?_TF9CX7_P#(US7_`+$N,_\` M24?+UU_Q]77_`%]7'_HYZ^ZP7^Z87_KQ3_\`24?GV8?[[C/^PBM_Z6S]@_V7 M;*"Q^"7@PP*%-W!>7TYZ%II[Z?>QQU/``SV`]*_F_C:I.IQ)F',_@G&$5_+% M13279:W]3^JO#RE"EPIEKC%1=2#G*VC@)DC@#SS%R>,X`&2,=WAVXKB7#J5D_8UE'IK9-V^5SSO%-3_P!5<0XI M\L:U'FZ)7EI<_*33[&ZU*^LM-LH_,O+^ZAL[2(.L7F7-PZQQ(' M>VJLT>Z?\,R?''MX/N`/^PSIO(/_`&_5\5_KUPHM.>-[O7ZM;_VP^^7A[QC9 M6I5(JR:MB*FS5TM)!_PS'\<>G_"'SX]#K&FD?E]NQCZBG'CSA6'PU%%K9QPW M*U]T%J#\.^,'%Q=*IR]8NM-I^J&_%-.O2E]4BE"I&5U*UK/='Z[^';>Z MM/#^A6MZI2]MM&TRWNT)5BMU#901W"ED^4E95<$K\IQD<8K\!S"I2JX_&U:' M\&IB\34H]/W4ZTY4]'K\#1_3654:N'RO+G"IK_`(HL M_*KXP:I_PE7[336>LR;-,L/&/A[PT$F)6*+3+2_M(I@=V`D=S)+/(6&%VS"1 MCCFOW/(<,\LX)G5P:YL15P2QGNJ[=3$4(U>6RU;7-RVW=D?SCQ)BO[2X^='% MR<:&'Q]7")2=HJGA\34IP:OI:T4?K3&J1QQI&`D:(JH%P%"A0%``X```X';' M:OP.3?,^:_,VY.^]V[OYW/Z:I1C"G3C32Y(P@HVT7*HI*UNENQ)4^7_`+V\O MT/FS]J7P!>>.?AC=/I-NUSJ_AF[CURTMH@3+4O:M1HXE?5Y2>BC*;]R5]K7NO5H_/_`!%R2IG&0U/81O6P M<_K"BMW&,?>22UOMIZL_(NVN)[*XM[NTE:"ZM)X[BWF0[9(+B"0/$Z]PR2*# MC`Y&#Z5_1E2%+%4)TW:5*I&46NCC-6TZ:IG\M4IUL%B(5(\U.M0J)K=-2A*] MNEMC]*_AO^V3X3O=*M+#X@P7>AZU:PQPW&IVMN]WI>H.BA3X>RII>SH4]+PI)WC%M=>[Z MGOW[+G@B];0/BEX_N8'BT^'P5X@\/Z7*ZE1O\`C',K MZ?N/3>7V9"XQ_Y)K-O^P;_P!O MB?B,O"+VPJ_AG%?U#-?N9)=(;;6T/X^A95H]O::?^!'UG^U1U^#WM\--,_5+ M:OSKP_\`=JY]T_X4\3\O?/TWQ'LJ7#_?^R\'IM;]PBM^R+Q\1/$G;'P[\1^V M,W.EUOXC_P#(KR[2R6;X;RWC/[C'POTS7->ELEQGEO%'R]=?\?5T/^GJXX_[ M;/7W6"_W3"V_Y\T]-OLH_/G[GTW;.P^+7@O_`(3_`.'?B?PJ MFU;C4-.=K!F'":A:,MW8MV`/VF&,9[9S7G9#F#RG-L'C?AC1JI3MI:G43A-_ M*,FST^)\J_M?),=@%O.DYP7>=/WXQ]9-67FT?B.Z:CH>J&.:.6PU;1[\;XI% M*2VE_87`.UT(!#1S1#(Z,!G)4@U_4*^K9A@UR24J&)I63B[Q<91_+7YH_C]Q MQ&58ZTH.E7PE;6+5G&49?+I^9^L_PT_:;^''BO0M/_MW7['POXBAMHHM3T_6 M)EM(3L\X)SG+L566&PL\3A.>4J=6 MBK^XW=1E#XKJ_+HG>U]#^F^'?$'(\PP.'6*Q,,%C(4X0J4JE]7%*/-&25M;7 M:>S?R,3XM?M4^"?"FB7EIX(U:S\3>*YXFAL#8C[5I>FRL,"]OKGY;>>.+EEM M[>21I6PK%%R:Z^'^`\TS#$TY8_#SP>!@TZCG[M2I'^2FHW<;]9.UEI;6YS<3 M^)&4Y9A*E/*Z\<7CY1<:7(FJ=&7\T^9+FZJRMNG<^=OAM^T-\>_B!XUT#PI8 MZGHK?VA>Q&_EC\/0#[)I<#+)J%VQ$Q$82W#A">#*\:C.:^PS[@WA?)9<[O?2 MT=3].P"``3D@`$],D=3BOQ'\/+L?T,DTDF[M))O:[2U=CY)^-/[+6G_$?7)O M%WAS6O\`A&_$ER(OMZS0-/IM_-`H6*[80O%<6UV%5%::)F$FQ&9=RY/WW#?' M%;)<,L!B<.L5@T[1UM4IP:MRI/W7%+X4VK+2^A^9<5^'=#.\6\QP-;ZIC;N4 MD_=A.?,YN?-JU*4FV]+7UOK8M^$?#'[4?ABVM])N?%/@#7].M$6""YUF'5)+ M]88P$3S)[>.&6;"`?ZTM(UO,];L-"^*-WM_M_Q MGHNG1G_66_ACP^0Y!QD)>ZK=7+Q$\_,+=CSP!7SLZ^64I/ZOA*M1+1?6:CBM M>KC3Z]ES?>?54<-G%2*6*QE/#O?EPL$[:?S3BK*YW>E:1'I4$D/VR_OWF8-- M<:E5+]=/O/4HX=482C*4 MJG-\;JMNS/CW6/V8_C5H MLKQ#P?+JJ*V%GT:[M;R)P#PR*9(IP#UP8@PSRHK]+PG'G#N)4?\`:XX9]8XB M4*"75J\W%+[['Y-B_#KB?!3I+D64XVEKO5P>*IQU\Y4DCWSX>_L6^(+NZ@O/B-JMKI6FHRR M2:-HLQNM1N%!#&&:^V+;VBOT!-2\'>%K"VTZT'AS4](TNSCQ%"DMSI\]M$97P26DED5IYWW.[%I'+,3G\F^ MO5:^8TL=C*DJD_K5*M5D[MVC5C-J*Z))645Z(_:O[+H87*,1EF`I0H4W@Z^' MHP6BYJE&<$Y/O*33;/S)C_8Z^,RQ(GV;PYE452/[:&,A0#@_9@,9_.OW)^)/ M#_+;_:5:+7\)]58_G:/A3Q,IK3"I*5_XCZ2OV/TO^&'A[4?"?P^\(>&]56%= M2T30=/T^]6WD\V!;FW@6.412[5WIN!VMM&[K7XCG&*I8W,\9BZ%_95ZSJ0YE M:5FENNA_0W#^!K99E&"P5>RJX>ER3Y=8WYF]'VU%^)WA_4?%/P_\6>'-)6(Z MEK&C75C9K/)Y,)GF4!!)+AO+3/5MIQZ4\DQ=++\UP6+KO961^:(_8[^,H4+]F\.<``_\`$ZQC M'_;M_GK7[7+Q(X?]GRKZRGRV_A-:V_`_GV/A5Q-&I&5L,E&=_P"(UUOV/>_C MG^S]\0O'W_"O?^$>ATAAX;\&66AZD+O4?LVV^@6$2"#]R_FQ91L2?+GCBOD> M%>+O1Y(-VA4E>-[;.VY]KQ?P-G&<0RJ.#5&^"P.'H55. M;BO:4Z:C+ELMKD/P`_9Z^(GPY\7ZSK7B2'2([*]\(ZQHT!LM1%S+]MO9K)X` MT8ACVQ%8)-TF3M.!CFM>+^,,ISK!8/#X/VRG0Q]'$34Z;@O9P4E)KI?71=3+ M@G@3.LAQV.KXQ4%3KY=B,+3Y)MOVM5)1NK:1[L\1G_8_^,;3SNMMX="O/-(N M=:`^5Y&89'V;C@_G7T^&\1N'Z-"A3E]9O3IPB[4FK.*LSY/%>%G$U7$UZD%A M5"K6J3C^\:M&4FU?3LS]$?@QX3U;P-\-/"OA;7%MTU71[*2"[6UE\^!9'N9I M1Y(L?0S+.,;C<-S*C7J*4%)$?[616(6?2;^RN(7&10>N'C4CN*_4\-Q M]P[B(IO$JAIK&ORTVFUK\32^X_&\5X<\48*;C'!U:UG92PM*M53\[TX-%_P] M^RC\9=9GCBN=`MO#ELS`276L7]N@A0D;F%O9O<32,!R$4#TZ9K>4ZMXEU&-$U379HEC8HN&^QV,7)M;)7^;9N:29L22L3@#\ M>XDXHQG$-=.I^XPM-_N